OR WAIT 15 SECS
© 2021 MJH Life Sciences and Drug Topics. All rights reserved.
© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
February 17, 2021
In addition to reducing the frequency of migraine days, galcanezumab may also potentially decrease disabling non-pain symptoms of migraine on days when migraine is present.
February 10, 2021
The relatively new biologic therapies for migraine demonstrated low immunogenicity rates and rare adverse events.
January 22, 2021
Patients reported more frequent and severe migraines, along with overuse of analgesics.
January 11, 2021
Tanvee Thakur, PhD, BPharm, recently completed a project focused on enhancing transparent opioid education.
January 08, 2021
Elizabeth Dragatsi, RPh, BCPS, worked on 2 projects integrating community pharmacists into contingency management and opioid education.
December 31, 2020
Here are some of the top-read FDA approvals covered by Drug Topics® from this year.
December 28, 2020
The Drug Topics® team rounded up some of our top-read articles from the last year.
December 23, 2020
You’ll be hard pressed to find a pharmacist as excited about change as Ashli Yoder, PharmD, the clinical services lead for Norland Avenue Pharmacy in Chambersburg, Pennsylvania.
December 21, 2020
Acetaminophen injection, 1000 mg/100 mL, is an FDA-approved generic to Ofirmev.
December 17, 2020
US prescription opioid use dropped 60% from its peak volume in 2011, according to a new report from the IQVIA Institute for Human Data Science.